Hand-Foot Skin Reaction with Sunitinib: A Rare Case Report with Review of Literature

Newer multi-kinase inhibitors (MKI) like sunitinib have changed the therapy of patients of renal cell carcinoma, hepatocellular carcinoma, and gastrointestinal stromal tumor. The use of sunitinib also led to cutaneous toxicity, known as hand-foot skin reaction (HFSR). We report a case of hand-foot s...

Descripción completa

Detalles Bibliográficos
Autores principales: Das, Suchibrata, Roy, Alok K, Barman, Srutee, Roy, Aritra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7810063/
https://www.ncbi.nlm.nih.gov/pubmed/33487712
http://dx.doi.org/10.4103/ijd.IJD_481_20
Descripción
Sumario:Newer multi-kinase inhibitors (MKI) like sunitinib have changed the therapy of patients of renal cell carcinoma, hepatocellular carcinoma, and gastrointestinal stromal tumor. The use of sunitinib also led to cutaneous toxicity, known as hand-foot skin reaction (HFSR). We report a case of hand-foot skin reaction (HFSR) in an Indian patient being treated with sunitinib. Respective literature on this disorder is also reviewed.

Ejemplares similares